Identification of E. dysenterica laxative peptide: A novel strategy in the treatment of chronic constipation and irritable bowel syndrome

Peptides

Volumn 31, Issue 8, 2010, Pages 1426-1433

  Lima, T B ^a   Silva, O N ^a,b   Oliveira, J T A ^c   Vasconcelos, I M ^c   Scalabrin, F B ^a   Rocha, T L ^d   Grossi de Sa M F ^a,d   Silva, L P ^d   Guadagnin, R V ^a   Quirino, B F ^a   de Souza Castro, Carlos Frederico ^e   Leonardecz, E ^e   Franco, O L ^a,b  

^a UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^d EMBRAPA RECURSOS GENÉTICOS E BIOTECNOLOGIA   (Brazil)

^e UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Bioactive peptides; E. dysenterica; Hemolytic active; Laxative

Indexed keywords

EUGENIA DYSENTERICA EXTRACT; LAXATIVE; PEPTIDE; PLANT EXTRACT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONSTIPATION; CONTROLLED STUDY; DRUG ACTIVITY; EUGENIA; EUGENIA DYSENTERICA; GASTROINTESTINAL TRANSIT; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IN VITRO STUDY; INTESTINE MOTILITY; IRRITABLE COLON; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; RAT;

EUGENIA DYSENTERICA; MAMMALIA; RATTUS;

EID: 77958449388     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.05.003     Document Type: Article

References (44)

1. Abdullahi AL, Agho MO, Amos S, Gamaniel KS, Wambebe C. Antidiarrhoeal activity of the aqueous extract of Terminalia avicennoides roots. Phytother Res 2001;15:431-434
2. Akah PA, Offiah AVN. Gastrointestinal effects of Allamanda cathartica leaf extracts. Pharm Biol 1992;30:213-217
3. Alexander JC. Biological effects due to changes in fats during heating. J Am Oil Chem Soc 1978;55:711-717
4. Aparicio RM, Jose Garcia-CelmaM, Pilar Vinardell M, Mitjans M. In vitro studies of the hemolytic activity of microemulsions in human erythrocytes. J Pharm Biomed Anal 2005;39:1063-1067
5. Axelsson LG, Wallin B, Gillberg PG, Sjoberg B, Soderberg C, Hellstrom PM. Regulatory role of 5-HT and muscarinic receptor antagonists on the migrating myoelectric complex in rats. Eur J Pharmacol 2003;467:211-218
6. Barraviera B, Coelho KY, Curi PR, Meira DA. Liver dysfunction in patients bitten by Crotalus Durissus terrificus (Laurenti, 1768) snakes in Botucatu (State of Sao Paulo, Brazil). Rev Inst Med Trop Sao Paulo 1995;37:63-69
7. Beloosesky Y, Grinblat J, Weiss A, Grosman B, Gafter U, Chagnac A. Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch Intern Med 2003;163:803-808
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254
9. Camilleri M, Bharucha AE, Ueno R, Burton D, Thomforde GM, Baxter K, et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.AmJ Physiol Gastrointest Liver Physiol 2006;290:G942-7.
10. Cline WS, Lorenzsonn V, Benz L, Bass P, Olsen WA. The effects of sodium ricinoleate on small intestinal function and structure. J Clin Invest 1976;58:380-390
11. Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 2009;61:430-481
12. Dunnick JK, Hailey JR. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res 1996;56:4922-4926
13. Edman P. A method for the determination of amino acid sequence in peptides. Arch Biochem 1949;22:475.
14. Eglen RM, Hegde SS, Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 1996;48:531-565
15. Ellery AW. Guidelines for specification of animals and husbandry methods when reporting the results of animal experiments. Working Committee for the Biological Characterization of Laboratory Animals/GV-SOLAS. Lab Anim 1985;19:106-108
16. Gadacz TR, Gaginella TS, Phillips SF. Inhibition of water absorption by ricinoleic acid. Evidence against hormonal mediation of the effect. Am J Dig Dis 1976;21:859-862
17. Gaginella TS, Chadwick VS, Debongnie JC, Lewis JC, Phillips SF. Perfusion of rabbit colon with ricinoleic acid: dose-related mucosal injury, fluid secretion, and increased permeability. Gastroenterology 1977;73:95-101.
18. Han DW. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 2002;8:961-965
19. Johnston JM, Kurtz CB, Drossman DA, Lembo AJ, Jeglinski BI, MacDougall JE, et al. Pilot study on the effect of linaclotide in patients with chronic constipation. Am J Gastroenterol 2009;104:125-132
20. Kere J, Hoglund P. Inherited disorders of ion transport in the intestine. Curr Opin Genet Dev 2000;10:306-309
21. Kimmel SE, Waddell LS, Michel KE. Hypomagnesemia and hypocalcemia associated with protein-losing enteropathy in Yorkshire terriers: five cases (1992-1998). J Am Vet Med Assoc 2000;217:703-706
22. Laitinen L, Takala E, Vuorela H, Vuorela P, Kaukonen AM, Marvola M. Anthranoid laxatives influence the absorption of poorly permeable drugs in human intestinal cell culture model (Caco-2). Eur J Pharm Biopharm 2007;66:135-145
23. Lambert JC, Zhou Z, Wang L, Song Z, McClain CJ, Kang YJ. Preservation of intestinal structural integrity by zinc is independent of metallothionein in alcohol-intoxicated mice. Am J Pathol 2004;164:1959-1966
24. Luna LG. Histopathologic methods and color atlas of special stains and tissue artifacts. Maryland: Jhonson Printers; 1992.
25. Moe SM. Disorders involving calcium, phosphorus, and magnesium. Prim Care 2008;35:215-237, v-vi.
26. Moeser AJ, Nighot PK, Roerig B, Ueno R, Blikslager AT. Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine. World J Gastroenterol 2008;14:6012-6017
27. Nascimbeni R, Donato F, Ghirardi M, Mariani P, Villanacci V, Salerni B. Constipation, anthranoid laxatives, melanosis coli, and colon cancer: a risk assessment using aberrant crypt foci. Cancer Epidemiol Biomarkers Prev 2002;11:753-757
28. Nelson R, Norton N, Cautley E, Furner S. Community-based prevalence of anal incontinence. JAMA 1995;274:559-561
29. Nwafor PA, Okwuasaba FK, Binda LG. Antidiarrhoeal and antiulcerogenic effects of methanolic extract of asparagus pubescent rootin rats. J Ethnopharmacol 2000;72:421-427
30. Owen RT. Lubiprostone - a novel treatment for irritable bowel syndrome with constipation. Drugs Today (Barc) 2008;44:645-652
31. Palhares D. Caracterização farmacognóstica das folhas de Eugenia dysenterica DC (Myrtaceae Jussieu). Revista Lecta 2003;21:29-36.
32. Pohl D, Tutuian R, Fried M. Pharmacologic treatment of constipation: what is new? Curr Opin Pharmacol 2008;8:724-728
33. Przyborski SA, Levin RJ. Cholinergic modulation of electrogenic ion transport in different regions of the rat small intestine. J Pharm Pharmacol 1997;49:691-697
34. Ridder WJ, Schuurkes JA. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine 1,2,3,4 receptors. J Pharmacol Exp Ther 1993;264:79-88.
35. Saputera, Mangunwidjaja D, Raharja S, Kardono LB, Iswantini D. Characteristics, efficacy and safety testing of standardized extract of Croton tiglium seed from Indonesia as laxative material. Pak J Biol Sci 2008;11:618-622
36. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:368-379
37. Shibayama Y. An experimental study on the pathogenesis of acute haemorrhagic enteropathy significance of congestion and endotoxaemia. J Pathol 1986;148:169-174
38. Shoba FG, Thomas M. Study of antidiarrhoeal activity of four medicinal plants in castor-oil induced diarrhoea. J Ethnopharmacol 2001;76:73-76
39. Tack J, Muller-Lissner S. Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol 2009;7:502-508
40. Tsai JC, Tsai S, Chang WC. Effect of ethanol extracts of three Chinese medicinal plants with anti-diarrheal properties on ion transport of the rat intestinal epithelia. J Pharmacol Sci 2004;94:60-66
41. Van Gorkom BA, de Vries EG, Karrenbeld A, Kleibeuker JH. Review article: anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther 1999;13:443-452
42. Vasconcellos MC, Bezerra DP, Fonseca AM, Pereira MR, Lemos TL, Pessoa OD, et al. Antitumor activity of biflorin, an o-naphthoquinone isolated from Capraria biflora. Biol Pharm Bull 2007;30:1416-1421
43. Vu MK, Nouwens MA, Biemond I, Lamers CB, Masclee AA. The osmotic laxative magnesium sulphate activates the ileal brake. Aliment Pharmacol Ther 2000;14:587-595
44. Woodard JC, Webster PD, Carr AA. Primary hypomagnesemia with secondary hypocalcemia, diarrhea and insensitivity to parathyroid hormone. Am J Dig Dis 1972;17:612-618